JPM Report: Chinese Insurers Lag Behind Market; PING AN and CHINA LIFE Recommended
Market Performance: After the Lunar New Year holiday, Chinese H-listed insurers have underperformed, with concerns about short-term profit risks and a lack of disclosed premium income data.
JPMorgan's Analysis: JPMorgan's report indicates that major insurers like PING AN and CHINA LIFE are rated as Overweight, with target prices set at $100 and $40, respectively, due to their recovery in life insurance sales.
Profit Forecasts: JPMorgan forecasts significant growth in FY2025 net profits for CHINA LIFE (47%), PING AN (19%), and CPIC (10%) year-over-year.
Short Selling Activity: There is notable short selling activity in both PING AN and CHINA LIFE, with respective ratios of 28.711% and 16.336%, reflecting market skepticism despite their growth prospects.
Trade with 70% Backtested Accuracy
Analyst Views on 02318
About the author
M Stanley's Updated Focus List for Hong Kong and China Stocks (Table)
Morgan Stanley's Market Strategy: The report highlights new additions to the focus list for Hong Kong and Chinese markets, including GIGADEVICE and SINOPEC CORP, while removing SUNNY OPTICAL and ESPRESSIF.
Stock Performance: Notable stock movements include SINOPEC CORP and CHALCO showing gains, while GIGADEVICE and SUNNY OPTICAL experienced declines, with significant short selling activity reported across various stocks.
UBS Anticipates Strong Operating Profit Growth for PING AN Last Year Amid Reduced Impairment Pressures
PING AN's Upcoming Results: PING AN is set to announce its 2025 results on March 26, with expectations of a 9% year-over-year growth in attributable operating profit, driven by reduced impairment losses and stronger property insurance profits.
UBS's Forecast and Ratings: UBS has adjusted its model for PING AN but maintained its net profit forecast for shareholders, keeping the target price at HKD88 and a Buy rating.
JPM Report: Chinese Insurers Lag Behind Market; PING AN and CHINA LIFE Recommended
Market Performance: After the Lunar New Year holiday, Chinese H-listed insurers have underperformed, with concerns about short-term profit risks and a lack of disclosed premium income data.
JPMorgan's Analysis: JPMorgan's report indicates that major insurers like PING AN and CHINA LIFE are rated as Overweight, with target prices set at $100 and $40, respectively, due to their recovery in life insurance sales.
Profit Forecasts: JPMorgan forecasts significant growth in FY2025 net profits for CHINA LIFE (47%), PING AN (19%), and CPIC (10%) year-over-year.
Short Selling Activity: There is notable short selling activity in both PING AN and CHINA LIFE, with respective ratios of 28.711% and 16.336%, reflecting market skepticism despite their growth prospects.
M Stanley's H-shr Focus List: A Research Overview (Table)
Stock Performance Overview: Various stocks are showing mixed performance, with Alibaba (BABA.US) up by 17.8% and CHALCO (601600.SH) increasing by 20.7%, while others like DUALITYBIO-B (09606.HK) and NARI (600406.SH) are experiencing slight declines.
Short Selling Activity: Significant short selling is noted in several stocks, including Tencent (00700.HK) with $1.04B and a ratio of 13.981%, indicating investor skepticism about these stocks.
Earnings Reports: HKEX (00388.HK) has posted strong earnings last quarter, maintaining an "Overweight" rating from JPM, suggesting positive investor sentiment.
Market Trends: The overall market shows a mix of gains and losses, with some stocks like SUNNY OPTICAL (02382.HK) and PING AN (02318.HK) experiencing modest increases amidst varying short selling ratios.
M Stanley Publishes Thematic Focus List Highlighting High Conviction Opportunities in APAC (Table)
Stock Performance: TSMC and Tencent saw positive gains, with Tencent increasing by 2.246%, while Samsung Electronics and NAURA experienced declines.
Short Selling Data: Significant short selling activity was noted, with TENCENT at a ratio of 13.981% and PING AN at 32.071%, indicating investor caution.
Market Insights: CLSA recommends Contract Development and Manufacturing Organizations (CDMOs) for their earnings visibility, highlighting WUXI APPTEC, WUXI BIO, and PHARMARON as top picks.
Market Delays: Stock quotes for Hong Kong and A Shares are delayed by at least 15 minutes, affecting real-time trading information.
Short Selling Activity Reaches $43.3B, Representing 20% of Eligible Securities Turnover at Market Close
Short Selling Turnover: The short selling turnover in the Hong Kong market reached $43.3 billion, accounting for 20% of the eligible securities turnover, slightly up from 19.8% on the previous trading day.
Top Short Selling Shares: The top five shares with the highest short selling amounts include TRACKER FUND (02800.HK) at $3.48 billion, CSOP HS TECH (03033.HK) at $2.88 billion, and BABA-W (09988.HK) at $1.50 billion.
Short Selling Ratios: TRACKER FUND has the highest short selling ratio at 46%, followed by CSOP HS TECH at 40.6%, and PING AN (02318.HK) at 35%.
Market Performance: The reported changes in share prices for the top shorted stocks include declines for TRACKER FUND, CSOP HS TECH, BABA-W, HSCEI ETF, and PING AN, indicating a bearish sentiment in the market.
M Stanley's Updated Focus List for Hong Kong and China Stocks (Table)
Morgan Stanley's Market Strategy: The report highlights new additions to the focus list for Hong Kong and Chinese markets, including GIGADEVICE and SINOPEC CORP, while removing SUNNY OPTICAL and ESPRESSIF.
Stock Performance: Notable stock movements include SINOPEC CORP and CHALCO showing gains, while GIGADEVICE and SUNNY OPTICAL experienced declines, with significant short selling activity reported across various stocks.
UBS Anticipates Strong Operating Profit Growth for PING AN Last Year Amid Reduced Impairment Pressures
PING AN's Upcoming Results: PING AN is set to announce its 2025 results on March 26, with expectations of a 9% year-over-year growth in attributable operating profit, driven by reduced impairment losses and stronger property insurance profits.
UBS's Forecast and Ratings: UBS has adjusted its model for PING AN but maintained its net profit forecast for shareholders, keeping the target price at HKD88 and a Buy rating.
JPM Report: Chinese Insurers Lag Behind Market; PING AN and CHINA LIFE Recommended
Market Performance: After the Lunar New Year holiday, Chinese H-listed insurers have underperformed, with concerns about short-term profit risks and a lack of disclosed premium income data.
JPMorgan's Analysis: JPMorgan's report indicates that major insurers like PING AN and CHINA LIFE are rated as Overweight, with target prices set at $100 and $40, respectively, due to their recovery in life insurance sales.
Profit Forecasts: JPMorgan forecasts significant growth in FY2025 net profits for CHINA LIFE (47%), PING AN (19%), and CPIC (10%) year-over-year.
Short Selling Activity: There is notable short selling activity in both PING AN and CHINA LIFE, with respective ratios of 28.711% and 16.336%, reflecting market skepticism despite their growth prospects.
M Stanley's H-shr Focus List: A Research Overview (Table)
Stock Performance Overview: Various stocks are showing mixed performance, with Alibaba (BABA.US) up by 17.8% and CHALCO (601600.SH) increasing by 20.7%, while others like DUALITYBIO-B (09606.HK) and NARI (600406.SH) are experiencing slight declines.
Short Selling Activity: Significant short selling is noted in several stocks, including Tencent (00700.HK) with $1.04B and a ratio of 13.981%, indicating investor skepticism about these stocks.
Earnings Reports: HKEX (00388.HK) has posted strong earnings last quarter, maintaining an "Overweight" rating from JPM, suggesting positive investor sentiment.
Market Trends: The overall market shows a mix of gains and losses, with some stocks like SUNNY OPTICAL (02382.HK) and PING AN (02318.HK) experiencing modest increases amidst varying short selling ratios.
M Stanley Publishes Thematic Focus List Highlighting High Conviction Opportunities in APAC (Table)
Stock Performance: TSMC and Tencent saw positive gains, with Tencent increasing by 2.246%, while Samsung Electronics and NAURA experienced declines.
Short Selling Data: Significant short selling activity was noted, with TENCENT at a ratio of 13.981% and PING AN at 32.071%, indicating investor caution.
Market Insights: CLSA recommends Contract Development and Manufacturing Organizations (CDMOs) for their earnings visibility, highlighting WUXI APPTEC, WUXI BIO, and PHARMARON as top picks.
Market Delays: Stock quotes for Hong Kong and A Shares are delayed by at least 15 minutes, affecting real-time trading information.
Short Selling Activity Reaches $43.3B, Representing 20% of Eligible Securities Turnover at Market Close
Short Selling Turnover: The short selling turnover in the Hong Kong market reached $43.3 billion, accounting for 20% of the eligible securities turnover, slightly up from 19.8% on the previous trading day.
Top Short Selling Shares: The top five shares with the highest short selling amounts include TRACKER FUND (02800.HK) at $3.48 billion, CSOP HS TECH (03033.HK) at $2.88 billion, and BABA-W (09988.HK) at $1.50 billion.
Short Selling Ratios: TRACKER FUND has the highest short selling ratio at 46%, followed by CSOP HS TECH at 40.6%, and PING AN (02318.HK) at 35%.
Market Performance: The reported changes in share prices for the top shorted stocks include declines for TRACKER FUND, CSOP HS TECH, BABA-W, HSCEI ETF, and PING AN, indicating a bearish sentiment in the market.
